Shopping Cart
- Remove All
- Your shopping cart is currently empty
LY377604 is a human β3-adrenergic receptor agonist (EC50: 2.4 nM) and β1/2-adrenergic receptor antagonist for the study of obesity.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | 120 € | In Stock | |
5 mg | 302 € | In Stock | |
10 mg | 448 € | In Stock | |
25 mg | 734 € | In Stock |
Description | LY377604 is a human β3-adrenergic receptor agonist (EC50: 2.4 nM) and β1/2-adrenergic receptor antagonist for the study of obesity. |
Targets&IC50 | β3-adrenoceptor (human):2.4 nM (EC50) |
In vitro | LY377604 is a β1- and β2-adrenergic receptor antagonist as well as a β3-adrenergic receptor agonist, causing a maximal increase in cyclic adenosine monophosphate (cAMP) levels with an EC50 of 2.4 nM[1]. |
In vivo | LY377604 administered orally at 10mg/kg increases diet-induced obesity in male Long-Evans rats by enhancing calorie expenditure[1]. |
Molecular Weight | 524.61 |
Formula | C31H32N4O4 |
Cas No. | 204592-94-9 |
Smiles | O(C[C@H](CNC(CC1=CC=C(OC2=CC=C(C(N)=O)C=N2)C=C1)(C)C)O)C3=C4C=5C(NC4=CC=C3)=CC=CC5 |
Relative Density. | 1.282 g/cm3 (Predicted) |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | |||||||||||||||||||||||||||||||||||
Solubility Information | DMSO: 80 mg/mL (152.49 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
|
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.